Home > Boards > US OTC > Medical - Drugs >


Add MLPH Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/22/2021 9:51:05 AM - Followers: 14 - Board type: Free - Posts Today: 0



Breaking Through the Pain Barrier


Molecular Pharmacology (USA) Limited, (MPL-USA) is a public, biotechnology company (OTCBB: MLPH) dedicated to the discovery and development of analgesic and anti-inflammatory products based on the proprietary MPL-TL (tripeptofen) compound. MPL-TL, an oligopeptide, is a new key active ingredient that targets a different part of the pain and inflammation cascade than other analgesic/anti-inflammatory drugs. It is the first significant new topical analgesic discovery in nearly 50 years and will drive new products and opportunity in the $36.5 billion analgesia and anti-inflammatory industry. Delivered through the skin, analgesic products based on MPL-TL are expected to be fast acting with localized effects and minimal anticipated drug interactions or side effects .

MPL USA holds the exclusive worldwide rights to develop new and fast-acting analgesic and anti-inflammatory products based on MPL-TL . The parent product for MPL-TL has been used and tested for nearly two decades and has been shown to be fast acting , safe and effective.

MPL's primary objectives are to:
• Refine and bring to clinical trials the first new class of analgesics in several decades.
• Gain American, Australian & European regulatory and marketing approval.
• Manufacture, sell or license MPL-TL as a new, key active ingredient.
MPL-TL100 is the first candidate complex based on MPL-TL. It is currently being tested in human clinical trials for lateral epicondylitis (tennis elbow).

(This link goes directly to MLPH's Platform Description)

Drug Discovery Research Centre
284 Oxford Street
Perth, WA 6007

Jeff Edwards, Technical Operations Development

Jeff Edwards has over twenty years experience in managing new technological innovations. He is experienced in production, intellectual property, regulatory affairs and quality systems. He is an award winning technology developer in his own right, and has worked across a range of medical and technology fields with organizations including Omni LifeScience, Genesis Biomedical, CollTech Australia, IBM, NCR and Intellect Electronics.

Dr. Maud Eijkenboom

Dr. Eikenboom is a consulting neuroscientist specialising in chronic neuropathic and inflammatory pain. She brings 8 years of expertise managing many of the preclinical studies in animals and clinical development aspects for Bayer Healthcare of Germany. Dr Eikenboom has worked in the Netherlands, Russia, Germany and Brazil and has recently settled in Australia.

Dr. Sal Abdi, Consultant

Dr. Sal Abdi is currently the Chief (LOA) of the Division of Pain Medicine in the Dept. of Anesthesiology, Perioperative Medicine and Pain Management; Professor, Clinical Anesthesiology; Director, Fellowship Program in Pain Medicine; and Medical Director, JMH University of Miami School of Medicine in Miami, Florida and Director of the Massachusetts General Hospital Pain Center Dept. of Anesthesia and Critical Care at MGH; and Assoc. Prof. Anesthesiology (Pending) at Harvard Medical School in Boston, Massachusetts. He is currently licensed in Massachusetts, Texas & Florida.

Dr. Chris Quirk, Dermatology and Clinical Medicine

Dr. Quirk is an Australian dermatologist who has been a teaching hospital consultant for 21 years and has conducted numerous trials for international pharmaceutical companies such as Roche, Novartis, 3M and Matrix and has served on advisory boards for Merck, Allergan and Roche. He has published 22 papers in international journals and most recently has presented at the World Congress of Dermatology in Paris and the World Congress on Cancers of the Skin in Seville.

(This link goes directly to MLPH's Market Analysis Report)



(This link goes directly to MLPH's News Link)




300,000,000 of common shares, par value $0.001

Issued and outstanding
08 May 2013 - 111,553,740 common shares, par value $0.001
Float 23,550,000

(This link goes directly to MLPH's SEC Filings


Investor Relations:
Jeff Edwards
Molecular Pharmacology (USA) Limited
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#69   MLPH SEC Suspension because of questions regarding the Renee 02/22/21 09:51:05 AM
#68   You got that right! rodman 11/03/16 03:27:47 PM
#67   I have a ..... dun dun dun dun king koopa 10/14/15 11:00:07 PM
#66   ~ Pump And Dump ~ Beware :) stock1ace1 10/14/15 10:46:10 AM
#65   Promo pump and then dump, once the front scappy 10/14/15 10:06:49 AM
#64   Some movers this week! DarkPool 10/14/15 09:53:57 AM
#63   and Orbitstocks as well put out an e-mail. dshade 10/14/15 09:51:40 AM
#62   Penny stock spy. Wolf of penny stocks Epic stock ccharon86 10/14/15 09:40:16 AM
#61   Already up 180%....what's going on with MLPH? Caveat Emptor 10/14/15 09:34:00 AM
#60   ANOTHER OTC POS gone dark(unregistered, non-reporting) WarMachine 03/05/15 09:11:37 PM
#59   Interesting HDOGTX! Grolden 03/05/15 02:21:38 PM
#58   MLPH 15-12g HDOGTX 03/05/15 02:06:10 PM
#57   Wow this be a risky buy but cheap rodman 10/30/14 10:19:15 AM
#56   Things haven't worked out they way I expected. e-ore 10/30/14 05:52:09 AM
#55   I suspect my investment in MLPH is worthless rodman 10/29/14 02:23:37 PM
#54   Excitement here today at MLPH may have to e-ore 03/26/14 03:16:43 PM
#53   MLPH is up by 100% kranthikumar 03/26/14 09:51:35 AM
#52   What would a company be worth if it's e-ore 11/24/13 03:51:28 PM
#51   Nice close today. Hopefully it holds up. ProfitChaser 10/16/13 10:17:16 PM
#50   What's coming to MLPH: e-ore 09/24/13 10:11:40 PM
#49   MLPH company profile updated at Bloomberg/Business Week. Deal e-ore 09/02/13 10:04:12 PM
#48   A patience play e-ore 08/22/13 03:34:19 PM
#47   This could be getting very hott, if and ~S.B.A.~ 08/22/13 01:32:50 PM
#46   Understood, just dabbled a little can always add Johnstown 08/21/13 12:22:35 PM
#45   Welcome. Patience play e-ore 08/21/13 12:21:28 PM
#44   Joined here today at 017 MLPH Johnstown 08/21/13 12:17:19 PM
#43   There was a one day p&d promo here e-ore 08/21/13 11:50:57 AM
#42   A long wants out @ .017 190k impatient ~S.B.A.~ 08/21/13 09:50:21 AM
#41   This move very nicely once production orders start ~S.B.A.~ 08/20/13 12:52:05 PM
#40   Will take time to develop unless it gets e-ore 08/19/13 09:52:20 PM
#39   Since the 8k of the deal there hasn't ~S.B.A.~ 08/19/13 09:32:25 PM
#38   Since inception the company has only incurred a HokieHead 07/23/13 10:23:55 AM
#37   Great deal for MLPH.. HokieHead 07/23/13 10:18:29 AM
#36   A $87.50 buy moved the 10k ask from HokieHead 07/23/13 10:11:10 AM
#35   The share structure here has not changed since HokieHead 07/23/13 09:52:30 AM
#34   Perry Robins endorsing their products will make this HokieHead 07/22/13 01:38:47 PM
#33   Hiding bids lol.. HokieHead 07/22/13 01:27:46 PM
#32   This dude is backing the MLPH products: HokieHead 07/22/13 01:21:07 PM
#31   Huge news... HokieHead 07/22/13 01:15:34 PM
#30   See: Current Report Filing (8-k), that's the reason alexis62 07/22/13 10:08:14 AM
#29   MLPH is up by 140% kranthikumar 07/22/13 10:03:56 AM
#28   Rather buy MILF than MLPH. wizardseye 06/07/12 03:21:52 PM
#27   Rather buy MILF than MLPH. willlbone 06/07/12 12:59:14 PM
#26   Holy buys batman. This thing going to fly... HokieHead 06/06/12 10:18:45 AM
#25   Freaking monster. No sellers. may bust .10 today HokieHead 06/06/12 09:49:57 AM
#24   $MLPH talk still under way! :) ulfahl 06/06/12 09:28:01 AM
#23   $MLPH more news coverage: ulfahl 06/06/12 09:19:13 AM
#22   $MLPH News coverage - looking for more movement! ulfahl 06/06/12 09:15:32 AM
#21   No Kidding LOL Capkewl 06/06/12 06:59:36 AM
#20   MLPH- NICE SS- OS 43.50M , AS 200M $$$TOCK 007 06/05/12 06:10:41 PM
Consent Preferences